Royal Fund Management’s Elevance Health ELV Stock Holding History

Royal Fund Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-578	Closed	-$225K	–	312
2025 Q2	$225K	Buy	+578	New	+$232K	0.02%	271
2023 Q4	–	Sell	-760	Closed	-$331K	–	306
2023 Q3	$331K	Sell	760 -70	-8%	-$31.8K	0.04%	225
2023 Q2	$369K	Sell	830 -15	-2%	-$6.92K	0.05%	221
2023 Q1	$389K	Buy	845 +13	+2%	+$6.19K	0.06%	223
2022 Q4	$427K	Buy	832 +360	+76%	+$183K	0.07%	188
2022 Q3	$214K	Hold	472	–	–	0.04%	204
2022 Q2	$227K	Hold	472	–	–	0.04%	189
2022 Q1	$231K	Hold	472	–	–	0.03%	190
2021 Q4	$218K	Buy	+472	New	+$199K	0.03%	180
2021 Q1	–	Sell	-2,194	Closed	-$704K	–	186
2020 Q4	$704K	Buy	+2,194	New	+$673K	0.15%	111
2020 Q2	–	Sell	-522	Closed	-$118K	–	259
2020 Q1	$118K	Hold	522	–	–	0.05%	178
2019 Q4	$157K	Hold	522	–	–	0.04%	167
2019 Q3	$125K	Buy	522 +11	+2%	+$3.01K	0.03%	172
2019 Q2	$144K	Hold	511	–	–	0.04%	156
2019 Q1	$146K	Hold	511	–	–	0.05%	143
2018 Q4	$134K	Hold	511	–	–	0.05%	131
2018 Q3	$140K	Hold	511	–	–	0.04%	132
2018 Q2	$121K	Hold	511	–	–	0.04%	138
2018 Q1	$112K	Sell	511 -7	-1%	-$1.64K	0.04%	145
2017 Q4	$116K	Buy	+518	New	+$110K	0.04%	145

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Royal Fund Management's ELV Position: Q3 2025 in Review

Royal Fund Management sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 578 shares — an estimated $225K sold.

Royal Fund Management first reported a position in ELV in Q4 2017 and held it in 20 quarters. The position peaked at $704K in Q4 2020. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

Royal Fund Management reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
Royal Fund Management sold 578 Elevance Health shares in Q3 2025, an estimated $225K.
Royal Fund Management first reported a position in Elevance Health in Q4 2017 and held it in 20 quarters.
Royal Fund Management's Elevance Health position peaked at $704K in Q4 2020.
1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Royal Fund Management's 13F filing for Q3 2025, filed 29 Oct 2025.